Study Of Asthma In Patients Of African Descent

Completed · Phase 4

Conditions studied: Asthma

In brief

This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic visits will include physical examination, medical history review and lung function tests. The purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is better in reducing the number of asthma exacerbations compared with another drug (fluticasone propionate alone)

Key facts

Study ID

NCT00102765

Run by

GlaxoSmithKline

People needed

479

Starts

2004-11-01

Expected to finish

2007-04-01

Last updated by the study team

2017-01-18

Who can join

Age: 12 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of asthma for at least 6 months.
• Taking a low-dose of an inhaled corticosteroid for at least one month prior to the study (such as fluticasone propionate or budesonide).

You may not qualify if…

• History of life-threatening asthma.
• Hospitalized for asthma within 3 months prior to the study.
• Current respiratory tract infection.
• Will not be able to attend clinic visits for the entire length of the study.
• Certain medical conditions that will make being in the study unsafe (such as congestive heart failure, uncontrolled hypertension, tuberculosis or certain drug allergies).

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Montgomery, Alabama, United States
• GSK Investigational Site — Muscle Shoals, Alabama, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Palmdale, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — Stockton, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Hartford, Connecticut, United States
• GSK Investigational Site — Washington D.C., District of Columbia, United States
• GSK Investigational Site — Washington D.C., District of Columbia, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Tallahassee, Florida, United States
• GSK Investigational Site — Atlanta, Georgia, United States
• GSK Investigational Site — Columbus, Georgia, United States
• GSK Investigational Site — Decatur, Georgia, United States
• GSK Investigational Site — Martinez, Georgia, United States
• GSK Investigational Site — Savannah, Georgia, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.